It is slightly over one and half decades since the first cases of acquired immunodeficiency syndrome (AIDS) were reported in the US. The first report of human immunodeficiency virus type 1 (HIV-1) infection in Uganda was by Serwadda in 1985, 1 and it has been recognized that Uganda is one of the most affected countries in sub-saharan Africa. Prevalence rates range from about 8% in rural areas 2 to 40% in some urban areas and trading centres, 3 and in rural south west Uganda where our study is based, half of all deaths among adults and over 80% of deaths among those aged 13-44 years were attributable to HIV-1 infection. 4 ' 5 While HIV-related causes of death have been well documented in developed countries, 67 in Africa data are scanty. The few studies from Africa have been autopsy series in large urban hospitals. 8 " 10 While undoubtedly important, these hospital, autopsy studies are highly selective and may not represent causes of HIV-associated deaths in the general population in Africa where the majority of AIDS patients die in rural areas without any health facilities.
In this paper, we report on causes of death in HIV-1 infected individuals and HIV-negative controls in an on-going rural population-based cohort in Uganda over a 6-year period ending December 1996.
Methods
In 1989, the Medical Research Council (MRC) Programme on AIDS established a population-based cohort of approximately 5000 adults aged > 13 years in rural Uganda, which is followed by annual census and serosurveys. 4 In 1990, a random selection of a third of all HlV-seropositive individuals identified from the baseline survey were invited to participate in a natural history cohort (NHC) as prevalent cases. All seroconverters identified over the subsequent years were invited to enrol as incident cases. Randomly selected, age-stratified HIV-seronegative controls were also invited to enrol.
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All participants are invited to attend the study clinic every 3 months, and are seen by one of two clinicians who complete a detailed questionnaire on medical history and physical examination. Participants are also encouraged to attend the clinic for investigation and treatment if they are ill between regular appointments. The clinicians maintain detailed case-notes in which relevant findings and treatment for routine and interim visits and hospital referrals are recorded. Participants are visited at home by the clinicians if too ill to attend the clinic, and referred to hospital if necessary. Transport and hospital expenses are provided by the MRC. Deaths and unreported illness are ascertained by home visitors. All clinic staff are blind to the HTV serostatus of participants in the NHC. All participants are encouraged to attend the HTV counselling and testing facilities provided by MRC in the adjacent study villages.
Unless participants have been seen very recently in the clinic, study clinicians visit relatives of the deceased to obtain detailed information on illnesses and events preceding death.
The causes of death were determined by two clinicians (MO and DM) independently reviewing the premorbid clinical and laboratory findings in the study database and participants' clinic records, and from the information obtained from relatives. If a participant died in hospital, the hospital notes or death certificate were also reviewed. The opinion of a third clinician not involved in the study was sought in cases of disagreement. Blindness to the deceased's HIV serostatus was maintained. It was not possible to perform an autopsy at the study clinic or local hospitals.
The cause of death was classified as wasting syndrome if the CDC definition was fulfilled i.e weight loss of >10% body weight, plus either unexplained chronic diarrhoea (> one month), or chronic weakness and unexplained prolonged fever. Basic laboratory facilities were available at the clinic for the diagnosis of malaria from blood slides and intestinal pathogens were identified on microscopy of faecal samples. Microbiological diagnosis became available in mid-1996.
Person years of observation (PYO) were calculated from the time of enrolment to death, or censored at the end of the study period (31 December 1996). Only four participants were unaccounted for at the end of 1996, and their follow-up was censored at 31 December 1995 when they were last known to be alive.
Results
Of 559 people invited to enrol into the NHC, 440 did so by the end of 1996. Of these, 107 were prevalent cases, 108 incident cases and 225 HIV-negative controls. Ninety-three out of 116 prevalent cases requested to join the cohort in 1990 had enrolled by the end of 1995. In January 1996, 20 prevalent cases identified in 1990 but not previously approached were invited to join the cohort and 14 of these were enrolled. High compliance rates have been maintained throughout the period of follow-up and of those still available in the study area during 1996, over 96% were seen at least once in the clinic during the year.
In all, 78 deaths occurred over the 6-year period: 63 deaths occurred in HTV-1 positive cases (53 prevalent and 10 incident cases) and 15 deaths in HIV-negative controls. By the end of 1996, 56% (52/93) of the prevalent cases requested to enrol in 1990, and 9% (10/108) the incident cases died compared with 7% (15/225) of the HIV negatives. One prevalent case enrolled in 1996 also died. Death rates were 16 (95% CI : 10-27) in the HIV negatives, 33 (95% CI : 18-61) in incident cases and 141 (95% CI : 108-185) per 1000 PYO in the prevalent cases. The age-adjusted rate ratios for death were 3.4 (95% CI: 1.5-7.7) for incident cases against negative controls and 10.6 (95% CI : 5.8-19.1) for prevalent cases against negative controls. The median age at death (range) for prevalent and incident cases was 34.0 (22-74) and 43.5 (23-80) years respectively, and that of HTV negatives was 54.0 years (20-87).
The age-specific death rates for males and females are shown in Table 1 . The age and gender distribution of deaths reflects HIV transmission patterns and hence the numbers of males and females recruited in the NHC. Almost half of all male deaths occurred in prevalent cases aged 30-49 years.
The causes of deaths of the 63 HIV-positive participants are shown in Table 2 . The main causes of death (number) were wasting syndrome (17, mean age 40.8 years, range 22-74), chronic diarrhoea (12, mean age 33.2 years, range 23-72), chest infection (6, mean age 40.8 yean, range 27-65) and cryptococcal meningitis (7, mean age 39.3 years, 24-68). Ten of these were incident cases, eight of whom had a cause of death established which were wasting syndrome (2); chronic diarrhoea (2); chest infection (1); Kaposi's sarcoma (1); cryptococcal meningitis (1) and mediastinal tumour (1).
Forty-two of participants had AIDS (WHO stage 4 12 ) at their last routine clinic visit, and 17 were in stage 3 of whom six were assessed as having died of AIDS (four wasting syndrome; two cryptococcal meningitis) and four had insufficient information about cause of death. Four were seen in stage 1 at their last visit, two of these died with AIDS (one wasting syndrome; one cryptococcal meningitis) and in the other the cause of death could not be ascertained. Thus, 88% (50/57) of participants were known to have died with AIDS.
The causes of death in the HIV-negative controls are shown in Table 3 . Two deaths in young men were related to the ingestion of alcohol. One died in mysterious circumstances within 24 hours of drinking with a suspicious group of men, and the other became unconscious after drinking large quantities of local spirit, and died following an epileptiform fit.
Cause of death could not be ascertained for six prevalent and two incident cases, and three negative controls due to lack of adequate information. Of the 55 HIV-1 positive cases with sufficient data, only three deaths were ascribed to non-HIV related causes (ruptured ectopic pregnancy, suicide and aspiration and inhalation of vomit). Thus 95% (52/55) of the HIV seropositives were assessed as having HTV-associated deaths. Of the HIVnegative controls with sufficient data, apart from one person who died of possible TB, there were no HTV-associated deaths. 
Discussion
The data presented here provide information on the causes of death in adults in a population-based cohort of HTV-infected individuals and their negative controls in rural Uganda. In late stage HTV disease it is often difficult to ascribe a death to a single cause and those presented here were, in the opinion of the doctors involved in the study, the main cause of death. Even in developed countries, considerable differences in frequency and type of AEDSdefining diseases diagnosed during life and at post mortem have been reported, 7 and autopsy provides accurate, precise data about the cause of death. However all reported autopsy series on people dying with HTV infection in Africa have been from hospitals in capital cities, 9 ' 10 an experience shared by a small minority of people. We accept that diagnostic limitations and inability to carry out autopsies may have led to reduced accuracy in diagnosis, low prevalence or misclassiEcation of some diseases and that causes could not be ascribed to all deaths in the cohort, but our findings are representative of deaths in a rural African population. Other studies have reported causes of death in HIV-infected and uninfected individuals using verbal autopsy. 5 ' However, these rely on the interpretation (and hence reporting) of signs and symptoms by relatives. In our study, we had detailed medical records including laboratory reports on most of those who died, and the relatives were interviewed by medical staff who had been providing medical care for the deceased.
By the end of 1996, we had accumulated data on 78 deaths and 29% of HIV-infected cases enrolled into the NHC had died compared to only 7% of the negative controls. The main causes of death (%) in the HIV-infected participants were: wasting syndrome (31%), chronic diarrhoea (22%), cryptococcal meningitis (13%) and chest infection (11%). In a womens' HTV-1 cohort in neighbouring Rwanda, 51% of 39 deaths were from wasting syndrome and a further 36% had chronic diarrhoea. 14 In contrast, Lucas found that tuberculosis, bacteraemia and cerebral toxoplasmosis caused 53% of deaths in a large city hospital in West Africa. 9 Although almost a third of deaths in the HIV-positive participants were from wasting syndrome, another 22% died from chronic diarrhoea. Since most participants with wasting syndrome had diarrhoea and most of those dying with chronic diarrhoea were wasted, the only difference between the two causes for most people was whether we identified a fecal pathogen which could have caused their symptoms within 6 months of death (and their symptoms did not resolve after treatment). Thus there is great overlap between these two causes of death, and many of those classified as wasting syndrome did not have a fecal specimen examined. Also, we relied on microscopy for the diagnosis of fecal pathogens as culture facilities have only recently become available at the clinic. Although rarely recognized as an entity in autopsy series, wasting syndrome has become the second most commonly reported AIDS diagnosis in the US with 18% of AIDS cases having wasting syndrome as their AIDS-indicator condition.
15 Sixty per cent of AIDS patients in an autopsy series in Mexico presented with wasting syndrome and the most common opportunistic infections at death were cytomegalovirus (69%), Mycobacterium tuberculosis (25%), and Pneumocystis carinii pneumonia (24%). 16 The longitudinal nature of this study allowed close monitoring of participants' health at the study clinic, or at home for those too sick to attend the study clinic, and this enabled us to accumulate reliable data. However, causes of death could not be ascribed for 11 cases (eight HIV-positive cases and three negative controls) due to lack of sufficient information on deaths occurring away from the study area compounded by lack of relatives in the area. This reflects the social disruption caused by HIV infection in Africa.
While other studies have documented tuberculosis (TB) as the largest attributable cause of death in HIV-infected individuals in Africa, only three of the participants in our study were thought to have died from tuberculosis and in only one case was this proven. Autopsy series from Africa have found that tuberculosis was present in 41% of selected patients dying with AIDS, 10 that it was the prime cause of death in 32% of HIV-positive cadavers and almost half of TB patients on whom there was sufficient data, had chronic diarrhoea on admission to hospital. 9 Tuberculosis is difficult to diagnose in HTV-1 infected people, and the West African study 9 suggests that some of the deaths we ascribed to wasting syndrome may well have been caused by TB. We now offer a trial of directly observed anti-TB therapy to all participants with possible symptoms of TB including wasting syndrome.
Of participants for whom a cause of death could be ascribed, 88% died with AIDS. This is in contrast to other studies in Africa where only 11% 13 and 66% 14 of deaths in HIV-positive subjects were reported to have been due to AIDS, based on the clinical case definition. In our study, we used the WHO staging system, and this, plus the quality and frequency of follow-up, probably accounts for the higher proportion of deaths from AIDS in our study. Survival following AIDS is usually short in Africa, 18 therefore the frequency of follow-up will determine the proportion of deaths with AIDS that are identified.
Although our results are not directly comparable with hospital series as we have limited diagnostic facilities, they do represent an unbiased selection of deaths in a rural area. The HTV positives have high death rates and die of HIV-related pathologies. The main causes of death were wasting syndrome, chronic diarrhoea and chest infections which reflect the WHO clinical case definition of AIDS. Cryptococcal meningitis is also a common cause of death in this population causing 13% of deaths in HIVpositive cases for whom a cause of death could be ascribed.
